Published in Amino Acids on March 28, 2007
Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol (2010) 2.80
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28
Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27
Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta (2011) 1.25
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med (2011) 1.23
Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes. Diabetes (2014) 1.03
Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol (2012) 0.98
The redox state of transglutaminase 2 controls arterial remodeling. PLoS One (2011) 0.97
Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells. Mol Cancer (2011) 0.94
Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation. PLoS One (2011) 0.94
Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. Int J Clin Exp Pathol (2008) 0.90
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90
β cell ER stress and the implications for immunogenicity in type 1 diabetes. Front Cell Dev Biol (2015) 0.90
Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways. Am J Physiol Renal Physiol (2009) 0.87
Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression. J Biol Chem (2012) 0.87
T cell epitopes and post-translationally modified epitopes in type 1 diabetes. Curr Diab Rep (2015) 0.86
Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3. J Biol Chem (2008) 0.85
Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study. Virchows Arch (2009) 0.85
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition. Oncotarget (2015) 0.84
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities. Blood (2012) 0.82
Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states. Cell Tissue Res (2014) 0.80
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. J Pathol (2011) 0.79
Bcr is a substrate for Transglutaminase 2 cross-linking activity. BMC Biochem (2011) 0.78
Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes. J Autoimmun (2016) 0.78
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. PLoS One (2013) 0.76
Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age. Rejuvenation Res (2013) 0.75
Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans. Int J Mol Sci (2016) 0.75
Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models. Sci Rep (2016) 0.75
Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block. J Cereb Blood Flow Metab (2013) 0.75
Lack of transglutaminase 2 diminished T-cell responses in mice. Immunology (2014) 0.75
Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes. Front Endocrinol (Lausanne) (2017) 0.75
Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth (2001) 3.47
Aftermath of surgery for anorectal cancer. Br Med J (1971) 3.27
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
The Second National Prevalence Survey of infection in hospitals--overview of the results. J Hosp Infect (1996) 2.32
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg (2005) 2.19
Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15
A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Commun Dis Rep CDR Rev (1994) 2.04
Predicting hospital mortality for patients in the intensive care unit: a comparison of artificial neural networks with logistic regression models. Crit Care Med (2001) 1.86
The nature and mode of action of the cellulolytic component C1 of Trichoderma koningii on native cellulose. Biochem J (1973) 1.85
Effects of leukotriene D on the airways in asthma. N Engl J Med (1983) 1.69
'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology (2002) 1.68
Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med (1986) 1.60
Cardiac growth after pediatric heart transplantation. Circulation (1992) 1.55
High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. J Biol Chem (1991) 1.49
Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids (2008) 1.47
A comparison of conventional culture and three rapid methods for the detection of Salmonella in poultry feeds and environmental samples. Lett Appl Microbiol (1995) 1.47
Transmission of multi-resistant strains of Salmonella typhimurium from cattle to man. Vet Rec (1995) 1.46
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br J Cancer (2011) 1.44
High initial nortriptyline doses in the treatment of depression. J Clin Psychiatry (1993) 1.39
External supply of oxygen to the atmospheres of the giant planets. Nature (1997) 1.39
Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids (2004) 1.38
Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc (1988) 1.38
Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem (1999) 1.35
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol Reprod Biol (2007) 1.29
4D deformation modeling of cortical disease progression in Alzheimer's dementia. Magn Reson Med (2001) 1.27
Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci (1997) 1.26
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). Atherosclerosis (2001) 1.25
Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies. Transplant Proc (1987) 1.25
Diagnosis and management of peripheral arterial disease. BMJ (2012) 1.24
Peer coaching: an intervention for individuals struggling with diabetes. Diabetes Educ (2002) 1.22
p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol (2003) 1.22
The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest (1997) 1.21
The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer (2007) 1.20
Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res (1998) 1.20
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ (2005) 1.17
Purification and properties of cyclopentanone oxygenase of Pseudomonas NCIB 9872. Eur J Biochem (1976) 1.17
Evaluation of liquid-based cytology in cervical screening of high-risk populations: a split study of colposcopy and genito-urinary medicine populations. Cytopathology (2002) 1.16
Regarding "Percutaneous ultrasound guided thrombin injection: a new method for treating postcatheterization femoral pseudoaneurysms". J Vasc Surg (1998) 1.15
Clinical manifestations and descriptive epidemiology of Lyme disease in New Jersey, 1978 to 1982. JAMA (1984) 1.13
The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13
Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J (1996) 1.11
A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. J Clin Pathol (2001) 1.10
Participation in dementia research: rates and correlates of capacity to give informed consent. J Med Ethics (2008) 1.06
Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg (1996) 1.06
Europe at biowork: challenges and prospects. Are Europe's education systems anticipating the needs of the growing biotech sector? Biotechnology (N Y) (1994) 1.05
Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit. Eur J Surg Oncol (2004) 1.04
Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem (1999) 1.04
Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol (1979) 1.04
Isolation and Characterization of a Cyclohexane-Metabolizing Xanthobacter sp. Appl Environ Microbiol (1985) 1.02
Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol (2013) 1.01
The metabolism of cyclopentanol by Pseudomonas N.C.I.B. 9872. Biochem J (1972) 1.01
A systematic review of dynamometry and its role in hand trauma assessment. Open Orthop J (2012) 1.01
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report. Ann Oncol (2012) 1.01
Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol (1999) 1.00
Isolation of Arcobacter spp. from a brackish environment. New Microbiol (2000) 1.00
Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene (1994) 1.00
The effect of B-mode ultrasonic image standardisation on the echodensity of symptomatic and asymptomatic carotid bifurcation plaques. Int Angiol (1998) 0.99
A comparative study: conventional preparation and ThinPrep 2000 in respiratory cytology. Cytopathology (2001) 0.99
Potentially pathogenic vibrios in brackish waters and mussels. J Appl Microbiol (2000) 0.99
A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell. Biochem J (1986) 0.98
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer. Br J Pharmacol (1996) 0.98
Where exactly is the deep inguinal ring in patients with inguinal hernias? Surg Radiol Anat (2003) 0.97
Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature. Open Orthop J (2011) 0.97
Adult immunizations. Ann Intern Med (1996) 0.97
Glutamate-evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures. FEBS Lett (2004) 0.97
Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res (2010) 0.96
Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. J Thromb Haemost (2010) 0.96
Hemispheric symptoms and carotid plaque echomorphology. J Vasc Surg (2000) 0.96
Computer simulation of magnetic resonance spectra employing homotopy. J Magn Reson (1998) 0.96
Iatrogenic prostatic granulomata. J Clin Pathol (1988) 0.96
Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res (1999) 0.96
Completing the molecular investigation into the HIV outbreak at Glenochil prison. Epidemiol Infect (1999) 0.95
Tissue transglutaminase in tumour progression: friend or foe? Amino Acids (2007) 0.95
The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett (1995) 0.95
Tissue engineering for bone production- stem cells, gene therapy and scaffolds. Open Orthop J (2011) 0.95
Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol (1997) 0.94
The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study. Aims and results of quality control. Int Angiol (2003) 0.93
Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis. Carcinogenesis (1985) 0.93
Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta (1991) 0.92
Diabetic retinopathy in Down's syndrome. Br J Ophthalmol (1998) 0.92
The standard primipara as a basis for inter-unit comparisons of maternity care. Br J Obstet Gynaecol (1996) 0.92
Improved fit by asymmetric tibial prosthesis for total knee arthroplasty. Med Eng Phys (1994) 0.92
Prevalence of lower respiratory tract infections in hospitalized patients in the United Kingdom and Eire--results from the Second National Prevalence Survey. J Hosp Infect (2000) 0.92
Spontaneous regression of metastatic Merkel cell carcinoma. Ir Med J (2010) 0.91
An international investigation of an outbreak of Legionnaires disease among UK and French tourists. Eur J Epidemiol (1996) 0.91
Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial. Angiology (2003) 0.91
[Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs]. Minerva Cardioangiol (2002) 0.91
Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. Eur J Cell Biol (1993) 0.90
Characterization of tissue transglutaminase in human osteoblast-like cells. J Bone Miner Res (2001) 0.90
Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells. J Neurosci Res (2003) 0.90
ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol (2008) 0.89
Detection of epsilon(gamma-glutamyl) lysine. Mol Cell Biochem (1984) 0.89
Leukocyte telomere length is associated with measures of subclinical atherosclerosis. Atherosclerosis (2010) 0.89
A prospective study of faecal bile acids and colorectal cancer. Eur J Cancer Prev (2000) 0.89
Transglutaminases in wound healing and inflammation. Prog Exp Tumor Res (2005) 0.89
The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism. Biochem J (1984) 0.89
The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus. Histopathology (1987) 0.89